Odyssey Health shareholders approve asset sale of neurological drug therapies to Oragenics

Odyssey Health, Inc.

Approved asset purchase agreement of neurological drug therapies and technologies to Oragenics, Inc.
Vote: 45,032,700 for, 333,249 against, 48,943 abstaining on the asset purchase agreement.
Approved adjournment proposal: 44,826,263 for, 255,690 against, 332,939 abstaining.
Special meeting held on December 7, 2023; results filed via 8-K Item 5.07.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Odyssey Health, Inc. shareholders approved Approval of the asset purchase agreement of its neurological drug therapies and technologies to Oragenics, Inc. (reported as Oragenics in context? Actually the text says "Odyssey Health, Inc. formerly known as Odyssey Group International, Inc. (“Odyssey”) held its Special Meeting of Stockholders. At at the 2023-12-07 meeting.

Proposal: merger approval
Outcome: passed
Meeting: 2023-12-07

Exact text from the filing

(1) approved the asset purchase agreement of its neurological drug therapies and technologies to Oragenics, Inc.;

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Odyssey Health, Inc. shareholders approved Approval of adjournment or postponement of the Special Meeting, if necessary at the 2023-12-07 meeting.

Outcome: passed
Meeting: 2023-12-07

Exact text from the filing

(2) approved the adjournment or postponement of the Special Meeting, if necessary.

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Odyssey Health, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-008697

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.